Popular Design for American Ginseng Extract Wholesale to Eindhoven

Popular Design for American Ginseng Extract Wholesale to Eindhoven

Short Description:


Product Detail

Product Tags

, , ,
Popular Design for American Ginseng Extract Wholesale to Eindhoven Detail:

xys


Product detail pictures:

Popular Design for American Ginseng Extract Wholesale to Eindhoven detail pictures


Popular Design for American Ginseng Extract Wholesale to Eindhoven, The product will supply to all over the world, such as: , , ,



  • Biomarkers in Cardiovascular Disease 1st Edition (2016)

    ———(Video 1)
    –Part I: General Aspects 1
    -1. Testing Pharmacological Profiles with Biomarkers Relevant to Cardiovascular Profiles 3
    -2. Use of Multiple Biomarkers to Estimate Cardiovascular Drug Efficacy: Advantage of a PRE Score 27
    -3. Cardiovascular Disease Biomarkers in Clinical Use and Their Modulation by Functional Foods 39
    -4. Biomarker-Guided Therapy for Chronic Heart Failure 63
    –Part II: Circulating and Body Fluid Biomarkers 85
    -5. Biomarkers of the Extracellular Matrix and of Collagen Fragments 87
    -6. PCSK9 as a Biomarker of Cardiovascular Disease 125
    -7. Circulating Vasoactive Peptide Urotensin II and Relationships with Cardiovascular Disease 153
    -8. Association of Fetuin-A with Carotid Intima-Media Thickness and Vascular Diseases 177
    -9. Serum Cholinesterase Activities as Biomarkers of Cardiac Malfunctioning 197
    -10. Triglycerides (TG) to High-Density Lipoprotein (HDL-c) Ratio (TG/HDL-c Ratio) as a Marker of Cardiometabolic Risk 219
    -11. Biomarkers of Myocardial Cell Damage: Heart-Type Fatty Acid Binding Protein (H-FABP) for the Early Evaluation of Suspected Acute Coronary Syndrome 235
    -12. Uncarboxylated Matrix Gla Protein as a Biomarker in Cardiovascular Disease: Applications for Research and for Routine Diagnostics 267
    -13. MicroRNA-133: Biomarker and Mediator of Cardiovascular Diseases 285
    -14. Troponin Elevation Beyond Coronary Arteries 319
    -15. Circulating Vascular Endothelial Growth Factor-1 in Cardiovascular Disease 341
    -16. Macrophage Metalloprotease (MMP)-12 as a Cardiovascular Biomarker 359
    -17. Homocysteine as a Biomarker in Vascular Disease 381
    ———(Video 2)
    -18. Neutrophil Gelatinase Associated Lipocalin (NGAL) as a Biomarker for Cardiovascular Disease 407
    -19. Plasma Testosterone and Dihydrotestosterone as Markers of Heart Disease and Mortality in Older Men 425
    -20. Leukotrienes as Biomarkers of Cardiovascular Disease 449
    -21. Plasma 8-Isoprostane as a Biomarker and Applications to Cardiovascular Disease 467
    -22. Irisin Concentrations as a Myocardial Biomarker 489
    –Part III: Specific Diseases and Conditions 505
    -23. New Role of Biomarkers in Atrial Fibrillation 507
    -24. Biomarkers for Abdominal Aortic Aneurysm 541
    -25. Cardiac Biomarkers in Cirrhosis and Portal Hypertension: Relation to Circulatory and Cardiac Dysfunction 573
    -26. Disease Focused Approach on Fibrosis Biomarkers in Cardiovascular Health 601
    -27. Adiponectin as Biomarker in Coronary Artery Disease 635
    -28. Lipids and Lipoproteins as Biomarkers of Vascular Complications in Diabetes and Their Modulation by Dietary Phytochemicals 653
    -29. Gamma Glutamyltransferase (GGT) as a Biomarker of Atherosclerosis 673
    -30. Plasma Factor VIII Levels as a Biomarker for Venous Thromboembolism 703
    -31. Carotid Artery Stenting and Outcome Predictors 723
    –Part IV: Molecular, Cellular, and Histological Variables 737
    -32. RhoA/Rho-Associated Kinase as Marker of Cardiovascular Health 739
    -33. Polymorphisms in the Vitamin D Pathway in Relation to 25-Hydroxyvitamin D Status and Cardiovascular Disease Incidence: Application to Biomarkers 771
    -34. Nitric Oxide Regulating Proteins as Biochemical and Genetic Markers of Coronary Artery Disease 793
    ———(Video 2)
    -35. Nonsynonymous Single-Nucleotide Variations as Cardiovascular System Disease Biomarkers and Their Roles in Bridging Genomic and Proteomic Technologies 821
    -36. Cardiac Stem Cells as Biomarkers 849
    -37. Virtual Histology (VH) for Detecting Necrotic Core (NC) 877
    -38. Biomarkers of Coronary Plaque Composition and Vulnerability 897
    –Part V: Functional and Structural Variables 915
    -39. Pulse Pressure and Pulse Pressure Amplification as Biomarkers in Cardiovascular Disease 917
    -40. Ventricular Activation Time as a Marker for Diastolic Dysfunction 935
    -41. Markers of Cardiac Resynchronization Therapy 955
    -42. Adhesive Properties of Neutrophils as a Possible Biomarker of Vascular Disease 985
    -43. Comparing Cardiac Computed Tomography and Histology in Coronary Artery Stenosis 1005
    -44. Ultrasonic Measurement of Blood Flow Velocity and Applications for Cardiovascular Assessments 1025
    -45. Myocardial Blood Flow as a Biomarker 1057
    -46. Cerebral Blood Flow Measurement for Neurological Assessments: Functional Transcranial Doppler Ultrasound 1077
    -47. Epicardial Fat Thickness as a Biomarker in Cardiovascular Disease 1097
    -48. Electrocardiographic Markers of Torsadogenicity 1109
    -49. J Wave and Fragmented QRS Formation as a Biomarker 1135
    -50. Interpretation of Coronary Artery Disease with Intravascular Ultrasound 1163
    -51. Markers and Correlates of Right Ventricular Function with Computed Tomography, Echocardiography, and Magnetic Resonance 1183
    –Part VI: Resources 1221
    -52 Recommended Resources on Biomarkers in Cardiovascular Disease 1223

    Send your message to us:

    INQUIRY NOW
    • * CAPTCHA: Please select the Star

    Related Products

    INQUIRY NOW
    • * CAPTCHA: Please select the Cup

    WhatsApp Online Chat !